STOCK TITAN

Nexscient Financials

NXNT
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE June

This page shows Nexscient (NXNT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Nexscient passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality
0.77x

For every $1 of reported earnings, Nexscient generates $0.77 in operating cash flow (-$408K OCF vs -$530K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

Nexscient generated $0 in revenue in fiscal year 2025.

EBITDA
N/A
Net Income
-$530K
YoY+43.5%

Nexscient reported -$530K in net income in fiscal year 2025. This represents an increase of 43.5% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$100K
YoY+32.5%

Nexscient held $100K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
21M
YoY+4.4%

Nexscient had 21M shares outstanding in fiscal year 2025. This represents an increase of 4.4% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
$97K
YoY-52.6%

Nexscient invested $97K in research and development in fiscal year 2025. This represents a decrease of 52.6% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

NXNT Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $0 $0 N/A $0 $0 $0 N/A $0
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses $11K0.0% $11K N/A $0-100.0% $10K-85.7% $70K N/A $59K
SG&A Expenses $127K-12.1% $144K N/A $115K-23.5% $150K+159.2% $58K N/A $158K
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $12K-0.2% $12K N/A -$20K $0 $0 N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$149K+10.5% -$167K N/A -$135K+15.6% -$160K-25.2% -$128K N/A -$217K
EPS (Diluted) N/A N/A N/A $-0.010.0% $-0.01 N/A N/A $-0.01

NXNT Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $288K+22.1% $235K-21.9% $302K+66.8% $181K+91.0% $95K-48.4% $184K+47.6% $124K-46.5% $232K
Current Assets $115K+16.4% $99K-38.3% $160K+360.6% $35K-56.0% $79K-51.7% $163K+63.8% $100K-57.1% $232K
Cash & Equivalents $28K-51.7% $59K-41.3% $100K+370.0% $21K-73.0% $79K-47.8% $151K+99.8% $76K-55.3% $169K
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $784K+17.5% $667K+17.8% $566K+42.6% $397K+32.2% $300K+30.9% $229K+438.8% $43K+193.6% $15K
Current Liabilities $486K+368.6% $104K+59.7% $65K+23.4% $53K+92.5% $27K-42.9% $48K+32.1% $36K+149.7% $15K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$496K-14.9% -$432K-63.1% -$265K-22.4% -$216K-5.1% -$206K-348.6% -$46K-156.0% $82K-62.5% $218K
Retained Earnings -$1.9M-8.7% -$1.7M-10.7% -$1.6M-7.4% -$1.5M-10.2% -$1.3M-13.8% -$1.2M-12.4% -$1.0M-33.9% -$770K

NXNT Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow -$40K+55.8% -$92K-123.7% -$41K+61.1% -$105K+33.2% -$157K-50.8% -$104K+27.4% -$144K+19.4% -$178K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A $528K N/A N/A N/A $519K N/A
Financing Cash Flow $10K-80.0% $50K+112.3% -$408K-528.9% $95K+11.8% $85K-52.8% $180K+138.4% -$469K-548.6% $104K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

NXNT Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A -99.7%
Return on Assets -52.0%+18.9pp -70.9% N/A -74.6%+94.2pp -168.8%-99.2pp -69.5% N/A -93.5%
Current Ratio 0.24-0.7 0.95-1.5 2.47+1.8 0.66-2.2 2.89-0.5 3.42+0.7 2.76-13.3 16.03
Debt-to-Equity -1.58-0.0 -1.55+0.6 -2.14-0.3 -1.84-0.4 -1.46+3.5 -5.01-5.5 0.52+0.5 0.07
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$265K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Frequently Asked Questions

Nexscient (NXNT) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Nexscient (NXNT) reported a net income of -$530K in fiscal year 2025.

Nexscient (NXNT) generated -$408K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Nexscient (NXNT) had $302K in total assets as of fiscal year 2025, including both current and long-term assets.

Nexscient (NXNT) invested $97K in research and development during fiscal year 2025.

Nexscient (NXNT) had 21M shares outstanding as of fiscal year 2025.

Nexscient (NXNT) had a current ratio of 2.47 as of fiscal year 2025, which is generally considered healthy.

Nexscient (NXNT) had a debt-to-equity ratio of -2.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Nexscient (NXNT) had a return on assets of -175.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Nexscient (NXNT) had $100K in cash against an annual operating cash burn of $408K. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Nexscient (NXNT) has negative shareholder equity of -$265K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Nexscient (NXNT) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Nexscient (NXNT) has an earnings quality ratio of 0.77x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top